MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Carcinoma 256, Walker

(UMLS:C0007098)

Definition:: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)
UMLS ID:: C0007098
MeSH ID:: D002279

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.435.290.210|C04.557.450.795.290.210|C04.619.045

Synonym(s)

Carcinoma 256, Walker

Associated Drug(s)

	Name	Reference(s)	Data Source
1	Vitamin B 12	199903	CTD
2	Vitamin E	19781538	CTD
3	mecobalamin	199903	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Sarcoma, Experimental	37.1%
2	Hemangiosarcoma	37%
3	lymphangiosarcoma	37%
4	Chondrosarcoma	36.1%
5	leiomyosarcoma	36.1%
6	liposarcoma	36.1%
7	synovial sarcoma	36.1%
8	Clear Cell Sarcoma of Soft Tissue	36.1%
9	Alveolar Soft Part Sarcoma	36.1%
10	Carcinoma, Ehrlich Tumor	32.8%
11	Carcinoma, Lewis Lung	32.8%
12	Fibrosarcoma	32.4%
13	Osteosarcoma	32.4%
14	Sarcoma, Myeloid	32.1%
15	Sarcoma 180	31.2%
16	Leukemia, Experimental	31.2%
17	leukemia	30.8%
18	Neoplasms, Germ Cell and Embryonal	30.8%
19	Neoplasms, Glandular and Epithelial	30.8%
20	Germ Cell Cancer	30.8%
21	Malignant Fibrous Histiocytoma	30.5%
22	Neuroectodermal Tumors	29.9%
23	Neoplasms, Neuroepithelial	29.3%
24	Gliomatosis cerebri	29.3%
25	Mesenchymoma	28.6%
26	Hepatoblastoma	28.6%
27	Mixed Tumor, Mullerian	28.6%
28	Melanoma, Experimental	28.5%
29	Angiomyolipoma	28.2%
30	Phyllodes Tumor	27.6%
31	Desmoplastic Small Round Cell Tumor	27.6%
32	Endometrial Stromal Sarcoma	27.1%
33	Composite Lymphoma	26.8%
34	Rhabdomyosarcoma	26.1%
35	Hamartoma	25.8%
36	Neoplasms, Hormone-Dependent	25.8%
37	Neoplasms, Multiple Primary	25.8%
38	Paraneoplastic Syndromes	25.8%
39	Precancerous Conditions	25.8%
40	Neoplasms, Second Primary	25.8%
41	Leukemia L1210	25.7%
42	Leukemia P388	25.7%
43	melanoma	25.3%
44	Mammary Neoplasms, Experimental	25.1%
45	Histiocytic Disorders, Malignant	24.6%
46	Meningioma	24.4%
47	Dermatofibrosarcoma	24.2%
48	Dermatofibrosarcoma Protuberans	24.2%
49	Thymoma	23.7%
50	Medulloblastoma	23.2%
51	Trophoblastic Neoplasms	22.4%
52	Dermoid Cyst	22.1%
53	Adenoma, Acidophil	21.4%
54	Ganglioneuroma	21.4%
55	Glioma	21.4%
56	Malignant Glioma	21.4%
57	Alveolar rhabdomyosarcoma	21.1%
58	Giant Cell Tumor of Bone	20.8%
59	Leukemia, Plasma Cell	20.8%
60	Cyst	20.7%
61	Neoplastic Processes	20.7%
62	Neoplastic Syndromes, Hereditary	20.7%
63	Pregnancy Complications, Neoplastic	20.7%
64	Lymphoma	20.4%
65	Basal cell carcinoma	20.3%
66	Carcinoma, Papillary	20.3%
67	Squamous cell carcinoma	20.3%
68	Craniopharyngioma	20.3%
69	Cystadenoma	20.3%
70	Mesothelioma	20.3%
71	Neuroectodermal Tumor, Melanotic	20.3%
72	Neuroendocrine Tumors	20.3%
73	Carcinoma, Basal Cell	20.3%
74	Multiple Endocrine Neoplasia	19.8%
75	Neurofibrosarcoma	19.8%
76	Carcinoid Tumor	19.5%
77	Neurilemmoma	19.5%
78	Hutchinson's Melanotic Freckle	19.5%
79	Melanoma, Amelanotic	19.5%
80	Leukemia, Radiation-Induced	19.3%
81	Adenofibroma	18.8%
82	Fibroadenoma	18.8%
83	Adenoma	18.7%
84	Ameloblastoma	18.7%
85	Angiokeratoma	18.7%
86	Carcinoma	18.7%
87	Chordoma	18.7%
88	Hemangioma	18.7%
89	hemangiopericytoma	18.7%
90	Lymphangioma	18.7%
91	Nevus	18.7%
92	Teratoma	18.7%
93	Germinoma	18.7%
94	Teratocarcinoma	18.7%
95	Angiofibroma	18.7%
96	Epithelioma	18.7%
97	Choriocarcinoma	18.2%
98	Carcinoma, Lobular	18.2%
99	Cystadenocarcinoma	18%
100	Mucoepidermoid Carcinoma	18%
101	Acanthoma	17.8%
102	Lipoma	17.7%
103	Myoma	17.7%
104	Myxoma	17.7%
105	Angiolipoma	17.7%
106	Myelolipoma	17.7%
107	Neoplasms, Bone Tissue	17.7%
108	Neoplasms, Fibrous Tissue	17.7%
109	Smooth Muscle Tumor	17.7%
110	Chondroma	17.7%
111	Enchondroma	17.7%
112	Nephroblastoma	17.6%
113	Astrocytoma	17.5%
114	Ependymoma	17.5%
115	oligodendroglioma	17.5%
116	Ganglioglioma	17.5%
117	gliosarcoma	17.5%
118	Anaplastic astrocytoma	17.5%
119	Anaplastic Oligodendroglioma	17.5%
120	Liver Neoplasms, Experimental	17.5%
121	Lymphangioleiomyomatosis	17.2%
122	Neoplasms, Radiation-Induced	17%
123	Malignant Carcinoid Syndrome	16.6%
124	Paraneoplastic Encephalomyelitis	16.4%
125	Carcinosarcoma	16.2%
126	Retinoblastoma	15.8%
127	Bowen's Disease	15.6%
128	Paraganglioma	15.6%
129	Glioblastoma	15.6%
130	Neuroblastoma	15.6%
131	Glioblastoma Multiforme	15.6%
132	Carcinoma 256, Walker	15.5%
133	Mesoblastic Nephroma	15%
134	Plasmacytoma	15%
135	Malignant histiocytosis	14.9%
136	Histiocytic sarcoma	14.9%
137	Tuberous Sclerosis	14.8%
138	Abdominal Neoplasms	14.8%
139	Erythroplasia	14.8%
140	Follicular cyst	14.8%
141	Head and Neck Neoplasms	14.8%
142	Mucocele	14.8%
143	Pilonidal Cyst	14.8%
144	Soft Tissue Neoplasms	14.8%
145	Thoracic Neoplasms	14.8%
146	Thyroglossal Cyst	14.8%
147	Synovial Cyst	14.8%
148	Aberrant Crypt Foci	14.8%
149	Ganglioneuroblastoma	14.6%
150	Lymphomatoid Granulomatosis	13.8%
151	Pheochromocytoma	13.3%
152	Basal Cell Nevus Syndrome	13.3%
153	Carcinoid Heart Disease	13.1%
154	fibroma	13.1%
155	Fibromatosis	13.1%
156	Osteoblastoma	13.1%
157	Osteoma	13.1%
158	Rhabdomyoma	13.1%
159	Chondromatosis	13.1%
160	Multiple Endocrine Neoplasia Type 1	13%
161	Carcinoma, Pancreatic Ductal	12.8%
162	Adenocarcinoma	12.8%
163	Carcinoma in Situ	12.8%
164	Carcinoma, Transitional Cell	12.8%
165	Dysgerminoma	12.8%
166	Hemangioendothelioma	12.8%
167	Neuroma	12.8%
168	Papilloma	12.8%
169	Pseudomyxoma Peritonei	12.8%
170	Seminoma	12.8%
171	Papillomatosis	12.8%
172	Adenomatosis, Pulmonary	12.8%
173	Adenomatous Polyps	12.8%
174	Carcinoma, Large Cell	12.8%
175	Carcinoma, Small Cell	12.8%
176	Acoustic Neuroma	12.6%
177	Sarcoma	12.4%
178	Hodgkin Disease	12.3%
179	Lymphoma, Non-Hodgkin	12.3%
180	Digestive System Neoplasms	12.3%
181	Endocrine Gland Neoplasms	12.3%
182	Eye Neoplasms	12.3%
183	Nervous System Neoplasms	12.3%
184	Neoplasms, Experimental	12.1%
185	Mastocytosis	12%
186	Bone neoplasms	11.9%
187	Leukoplakia	11.9%
188	Lymphocele	11.9%
189	Pancreatic Cyst	11.9%
190	Skin Neoplasms	11.9%
191	Hematologic Neoplasms	11.9%
192	Gastrointestinal Stromal Tumors	11.8%
193	Barrett Esophagus	11.8%
194	Breast Cyst	11.8%
195	Actinic keratosis	11.8%
196	Mediastinal Cyst	11.8%
197	Neoplasm Invasiveness	11.8%
198	Neoplasm Metastasis	11.8%
199	Neoplasm Recurrence, Local	11.8%
200	Parovarian Cyst	11.8%
201	Pericardial Cyst	11.8%
202	Splenic Neoplasms	11.8%
203	Thymic Cyst	11.8%
204	Carcinogenesis	11.8%
205	Myxoid cyst	11.8%
206	Metastasis	11.8%
207	Optic Nerve Glioma	11.3%
208	Hepatocellular Adenoma	11.3%
209	Parathyroid Neoplasms	11.1%
210	Peritoneal Neoplasms	11.1%
211	Thyroid Neoplasm	11.1%
212	Thyroid carcinoma	11.1%
213	Vipoma	11.1%
214	Hydatidiform Mole	11.1%
215	Fibromatosis, Aggressive	10.8%
216	Fibromatosis, Abdominal	10.8%
217	Primary amyloidosis	10.6%
218	Mastocytoma	10.5%
219	Mastocytosis, Systemic	10.5%
220	Leukemia, Myelomonocytic, Chronic	10.2%
221	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	10.2%
222	Adenoid Cystic Carcinoma	9.8%
223	Adenocarcinoma, Clear Cell	9.8%
224	Cholangiocarcinoma	9.8%
225	Cervical Intraepithelial Neoplasia	9.8%
226	Hemangioblastoma	9.8%
227	Lymphoma, Extranodal NK-T-Cell	9.8%
228	Prolactinoma	9.8%
229	Growth Hormone-Secreting Pituitary Adenoma	9.8%
230	Pancreatic Neoplasm	9.8%
231	Corpus Luteum Cyst	9.7%
232	Ovarian Cysts	9.7%
233	Adenomatous Polyposis Coli	9.7%
234	Tracheal Neoplasms	9.6%
235	Retroperitoneal Neoplasms	9.5%
236	Leukoplakia, Oral	9.5%
237	Paraneoplastic Cerebellar Degeneration	9.4%
238	insulinoma	9.4%
239	Denys-Drash Syndrome	8.9%
240	Gastrinoma	8.7%
241	Glucagonoma	8.7%
242	granulosa cell tumor	8.7%
243	Carcinoma, Ovarian Epithelial	8.7%
244	Sturge-Weber Syndrome	8.6%
245	Hemangioma, Cavernous	8.5%
246	Choledochal Cyst	8.5%
247	Leukemia, T-Cell	8.4%
248	Leukemia, B-Cell	8.4%
249	neurofibroma	8.4%
250	Lymphoma, Follicular	8.4%
251	T-Cell Lymphoma	8.4%
252	Mantle cell lymphoma	8.4%
253	Klatskin Tumor	8.4%
254	Peutz-Jeghers Syndrome	8.3%
255	Esophageal Neoplasms	8.3%
256	Waldenstrom Macroglobulinemia	8.3%
257	Multiple Myeloma	8.3%
258	Limbic Encephalitis	8.2%
259	Leydig Cell Tumor	8.1%
260	Thyroid Nodule	8%
261	Leukemia, Myeloid, Chronic-Phase	7.8%
262	Mouth Neoplasms	7.7%
263	Central Nervous System Neoplasms	7.7%
264	Vascular Neoplasms	7.7%
265	Thymus Neoplasms	7.7%
266	Adrenocortical carcinoma	7.7%
267	Genital Neoplasms, Female	7.6%
268	Pancreatic Pseudocyst	7.6%
269	Lymphatic Metastasis	7.6%
270	Neoplasms, Unknown Primary	7.6%
271	Leukemic Infiltration	7.6%
272	Breast Neoplasms, Male	7.6%
273	Neoplasm Micrometastasis	7.6%
274	Triple Negative Breast Neoplasms	7.6%
275	Lambert-Eaton Myasthenic Syndrome	7.4%
276	Testicular Neoplasms	7.4%
277	Dupuytren Contracture	7.4%
278	Urticaria Pigmentosa	7.2%
279	Nasopharyngeal carcinoma	7.1%
280	Renal Cell Carcinoma	6.8%
281	Papillary Renal Cell Carcinoma	6.8%
282	Opsoclonus-Myoclonus Syndrome	6.7%
283	Carcinoma, Endometrioid	6.5%
284	Adrenal Gland Neoplasms	6.5%
285	Gastrointestinal Neoplasms	6.5%
286	Genital Neoplasms, Male	6.5%
287	Liver neoplasms	6.5%
288	Uveal Neoplasms	6.5%
289	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	6.5%
290	Leukemia, Large Granular Lymphocytic	6.5%
291	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	6.5%
292	Lymphoma, T-Cell, Cutaneous	6.5%
293	Lymphoma, AIDS-Related	6.5%
294	Enteropathy-Associated T-Cell Lymphoma	6.5%
295	Primary Effusion Lymphoma	6.5%
296	Urologic Neoplasms	6.4%
297	Sebaceous Gland Neoplasms	6.4%
298	Spinal Neoplasms	6.4%
299	Bone Marrow Neoplasms	6.4%
300	Polycystic Ovary Syndrome	6.3%
301	Myelitis, Transverse	6%
302	Nose Neoplasms	5.8%
303	Palatal Neoplasms	5.6%
304	Meningeal Neoplasms	5.6%
305	Mycosis Fungoides	5.5%
306	Lymphomatoid Papulosis	5.5%
307	Plasmablastic lymphoma	5.5%
308	Xeroderma Pigmentosum	5.3%
309	Pituitary Adenoma	5.2%
310	Pituitary Neoplasms	5.2%
311	Burkitt Lymphoma	4.9%
312	Ear Neoplasms	4.8%
313	Eyelid Neoplasms	4.8%
314	Lung Neoplasms	4.8%
315	Pleural Neoplasms	4.8%
316	ovarian neoplasm	4.8%
317	Cell Transformation, Viral	4.7%
318	Brain Neoplasms	4.7%
319	Salivary Gland Neoplasms	4.7%
320	Spinal Cord Neoplasms	4.7%
321	Tongue Neoplasms	4.7%
322	Uterine Neoplasms	4.6%
323	Vaginal Neoplasms	4.6%
324	Vulvar Neoplasms	4.6%
325	Uterine Cancer	4.6%
326	Fallopian Tube Neoplasms	4.6%
327	Meningeal Carcinomatosis	4.6%
328	Sezary Syndrome	4.2%
329	Pharyngeal Neoplasms	4.1%
330	Central Nervous System Cysts	4.1%
331	Bile Duct Neoplasms	4%
332	gallbladder neoplasm	4%
333	Intestinal Neoplasms	4%
334	Penile Neoplasms	4%
335	Prostatic Neoplasms	4%
336	Stomach Neoplasms	4%
337	Polycythemia Vera	4%
338	Bronchial Neoplasms	3.9%
339	Multiple Pulmonary Nodules	3.8%
340	Supratentorial Neoplasms	3.8%
341	Zollinger-Ellison syndrome	3.8%
342	Endometrial Neoplasms	3.8%
343	Laryngeal neoplasm	3.6%
344	Bladder Neoplasm	3.5%
345	Kidney Neoplasm	3.5%
346	Ureteral Neoplasms	3.5%
347	Urethral Neoplasms	3.5%
348	Brain Stem Neoplasms	3.4%
349	Hypopharyngeal Neoplasms	3.3%
350	Pleural Effusion, Malignant	3.3%
351	Hypopharyngeal Cancer	3.3%
352	Parotid Neoplasms	3.3%
353	Prostatic Neoplasms, Castration-Resistant	3.3%
354	Nelson Syndrome	3.2%
355	Choroid Plexus Papilloma	3.2%
356	Tonsillar Neoplasms	2.9%
357	Cerebellar Neoplasms	2.9%
358	Cecal Neoplasms	2.8%
359	Duodenal Neoplasms	2.8%
360	Nasopharyngeal Neoplasms	2.6%
361	Radicular Cyst	2.5%
362	Colorectal Neoplasms	2.5%
363	Appendiceal Neoplasms	2.5%
364	Colonic Neoplasms	2.5%
365	Rectal Neoplasms	2.5%
366	Paranasal Sinus Neoplasms	2.3%
367	Anus Neoplasms	2.1%
368	Sigmoid Neoplasms	2.1%
369	Maxillary Sinus Neoplasms	2%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234